Aflac AFL Cancer — Amortization of deferred policy acquisition costs

Other product segments

Similar metrics at other companies

EQHAmortization of deferred policy acquisition costs

$209M+11.2%

KMPRLife Insurance — Deferred Policy Acquisition Costs, Amortization Expense

$6.8M-4.2%

KMPRLife Insurance — Amortization of Deferred Policy Acquisition Costs

$7.38M-9.5%

VOYAAmortization of deferred policy acquisition costs

$65M+4.8%

BHFAmortization of deferred policy acquisition costs

$158M+6.8%

EIGInsurance Operations — Deferred policy acquisition cost, amortization expense

$30.8M+3.0%

Questions, answered.

What is Aflac's cancer — amortization of deferred policy acquisition costs?

Aflac (AFL) reported cancer — amortization of deferred policy acquisition costs of $46M in Q1 2026.

How has Aflac's cancer — amortization of deferred policy acquisition costs changed year-over-year?

Aflac's cancer — amortization of deferred policy acquisition costs decreased by 0.0% year-over-year, from $46M to $46M.

What is the long-term trend for Aflac's cancer — amortization of deferred policy acquisition costs?

Over 3 years (2022 to 2025), Aflac's cancer — amortization of deferred policy acquisition costs has grown at a 0.0% compound annual growth rate (CAGR), from $188M to $188M.

What does cancer — amortization of deferred policy acquisition costs mean?

The periodic expense recognized in the income statement representing the systematic allocation of deferred policy acquisition costs over the life of the cancer insurance policies. This aligns the cost of acquiring business with the revenue generated over time.